Peter D. Kies
2015
In 2015, Peter D. Kies earned a total compensation of $1M as Chief Financial Officer at Inovio Pharmaceuticals, a 12% decrease compared to previous year.
Compensation breakdown
| Bonus | $144,015 |
|---|---|
| Option Awards | $273,567 |
| Salary | $393,230 |
| Stock Awards | $189,000 |
| Other | $6,966 |
| Total | $1,006,778 |
Kies received $393.2K in salary, accounting for 39% of the total pay in 2015.
Kies also received $144K in bonus, $273.6K in option awards, $189K in stock awards and $7K in other compensation.
Rankings
In 2015, Peter D. Kies' compensation ranked 7,921st out of 13,638 executives tracked by ExecPay. In other words, Kies earned more than 41.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,921 out of 13,638 | 42nd |
Division Manufacturing | 3,007 out of 5,187 | 42nd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 392 out of 754 | 48th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 222 out of 460 | 52nd |
Industry Surgical and Medical Instruments and Apparatus | 122 out of 287 | 58th |
Source: SEC filing on March 29, 2017.
Kies' colleagues
We found three more compensation records of executives who worked with Peter D. Kies at Inovio Pharmaceuticals in 2015.
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021
Inovio Pharmaceuticals CEO J Kim's 2018 pay falls 30% to $3.1M
March 25, 2019